Tiger Pharmaceuticals (300347.SZ) released results for the first three quarters, with a net loss of 272 million yuan

According to Zhitong Finance App, Tiger Pharmaceuticals (300347.SZ) released its report for the third quarter of 2026. The company achieved operating income of 5.792 billion yuan in the first three quarters, up 15.23% year on year; net loss attributable to shareholders of listed companies of 272 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 450 million yuan, up 38.08% year on year; basic earnings per share -0.32 yuan.